SULFACETAMIDE SODIUM, SULFUR

N/A

Manufactured by Aurobindo Pharma Limited

251 FDA adverse event reports analyzed

Last updated: 2026-04-15

About SULFACETAMIDE SODIUM, SULFUR

SULFACETAMIDE SODIUM, SULFUR is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Aurobindo Pharma Limited. The most commonly reported adverse reactions for SULFACETAMIDE SODIUM, SULFUR include PAIN, DRUG INEFFECTIVE, NAUSEA, ANXIETY, ERYTHEMA. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for SULFACETAMIDE SODIUM, SULFUR.

Top Adverse Reactions

PAIN9 reports
DRUG INEFFECTIVE7 reports
NAUSEA7 reports
ANXIETY5 reports
ERYTHEMA5 reports
FALL5 reports
HYPERSENSITIVITY5 reports
RASH5 reports
ROSACEA5 reports
DRY SKIN4 reports
DYSPNOEA4 reports
EYE IRRITATION4 reports
MALAISE4 reports
PRODUCT SUBSTITUTION ISSUE4 reports
PULMONARY EMBOLISM4 reports
URTICARIA4 reports
ACNE3 reports
ASTHMA3 reports
CHEST PAIN3 reports
COUGH3 reports
DEPRESSION3 reports
DIARRHOEA3 reports
DIZZINESS3 reports
DYSPNOEA EXERTIONAL3 reports
HEADACHE3 reports
IMPAIRED QUALITY OF LIFE3 reports
INJECTION SITE PRURITUS3 reports
LETHARGY3 reports
NASOPHARYNGITIS3 reports
PRODUCT QUALITY ISSUE3 reports
PRURITUS3 reports
SKIN IRRITATION3 reports
SLEEP DISORDER3 reports
STAPHYLOCOCCAL INFECTION3 reports
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS3 reports
ABDOMINAL PAIN UPPER2 reports
ALOPECIA2 reports
ANTI NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS2 reports
ASTHENIA2 reports
BRAIN STEM ISCHAEMIA2 reports
CARDIAC MURMUR2 reports
CEREBROVASCULAR ACCIDENT2 reports
CHEILITIS2 reports
CHOLELITHIASIS2 reports
CHRONIC KIDNEY DISEASE2 reports
CONDITION AGGRAVATED2 reports
CONFUSIONAL STATE2 reports
DEEP VEIN THROMBOSIS2 reports
DERMATITIS CONTACT2 reports
ECONOMIC PROBLEM2 reports
EXPOSURE DURING PREGNANCY2 reports
FATIGUE2 reports
FEELING ABNORMAL2 reports
FEELING HOT2 reports
GASTROOESOPHAGEAL REFLUX DISEASE2 reports
IIIRD NERVE PARALYSIS2 reports
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION2 reports
INCORRECT DOSE ADMINISTERED2 reports
INFECTION2 reports
INJECTION SITE SWELLING2 reports
LYMPHADENOPATHY2 reports
NEPHROLITHIASIS2 reports
OEDEMA2 reports
OFF LABEL USE2 reports
OSTEOPOROSIS2 reports
OVARIAN CYST2 reports
PAIN IN EXTREMITY2 reports
PALLOR2 reports
PARAESTHESIA2 reports
PIGMENTATION DISORDER2 reports
PLATELET COUNT DECREASED2 reports
PRODUCTIVE COUGH2 reports
PSEUDOFOLLICULITIS BARBAE2 reports
PSORIATIC ARTHROPATHY2 reports
RASH PRURITIC2 reports
SKIN DISORDER2 reports
SKIN EXFOLIATION2 reports
SOMNOLENCE2 reports
THERAPEUTIC RESPONSE DECREASED2 reports
TREATMENT FAILURE2 reports
UPPER RESPIRATORY TRACT INFECTION2 reports
URINARY TRACT INFECTION2 reports
WEIGHT INCREASED2 reports
ABDOMINAL DISTENSION1 reports
ABNORMAL FAECES1 reports
ABORTION SPONTANEOUS1 reports
ACIDOSIS1 reports
ADENOMA BENIGN1 reports
ADNEXA UTERI MASS1 reports
ADVERSE DRUG REACTION1 reports
ANAEMIA1 reports
ANGIOEDEMA1 reports
ANHEDONIA1 reports
APPLICATION SITE BURN1 reports
APPLICATION SITE PAIN1 reports
ARRHYTHMIA1 reports
ARTHRALGIA1 reports
ARTHRITIS1 reports
ATELECTASIS1 reports
AUTOIMMUNE HEPATITIS1 reports

Report Outcomes

Out of 112 classified reports for SULFACETAMIDE SODIUM, SULFUR:

Serious 46.4%Non-Serious 53.6%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female72 (66.7%)
Male34 (31.5%)
Unknown2 (1.9%)

Reports by Age

Age 175 reports
Age 645 reports
Age 203 reports
Age 293 reports
Age 443 reports
Age 743 reports
Age 162 reports
Age 182 reports
Age 282 reports
Age 382 reports
Age 392 reports
Age 452 reports
Age 512 reports
Age 522 reports
Age 552 reports
Age 582 reports
Age 592 reports
Age 622 reports
Age 632 reports
Age 662 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with SULFACETAMIDE SODIUM, SULFUR?

This profile reflects 251 FDA FAERS reports that mention SULFACETAMIDE SODIUM, SULFUR. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for SULFACETAMIDE SODIUM, SULFUR?

Frequently reported terms in FAERS include PAIN, DRUG INEFFECTIVE, NAUSEA, ANXIETY, ERYTHEMA, FALL. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures SULFACETAMIDE SODIUM, SULFUR?

Labeling and FAERS entries often list Aurobindo Pharma Limited in connection with SULFACETAMIDE SODIUM, SULFUR. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.